About VAXART BIOSCIENCES INC
Vaxart is a clinical-stage biotechnology company developing oral recombinant pill vaccines based on an innovative delivery platform. The company focuses on transforming global health by creating safe, effective, and accessible vaccine solutions.
Development of oral recombinant pill vaccinesInnovative delivery platform technologyProprietary technology and partnerships for vaccine development
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| CLINICAL TRIAL PLANNING ACTIVITIES FOR A PHASE 2B CLINICAL TRIAL THAT COMPARES VAXART'S XBB VACCINE CANDIDATE | Department of Health and Human Services | $9.3M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to VAXART BIOSCIENCES INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.